title: [Anticancer agents: has the maximal tolerated price been reached?].
abstract: The cost of recent anticancer agents has skyrocketed and nothing appears to justify this huge increase except the willingness to cover of societies. It is urgent to discuss the pricing of anticancer agents with regard to their therapeutic value but also to that of other drugs.
authors: Hôpital Hautepierre, service de pharmacie, Strasbourg, France. dominique.leveque@chru-strasbourg.fr
authors: Dominique
authors: D
authors: Levêque
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics*; D003363:Cost Control / Q000191:economics; D003365:Costs and Cost Analysis; D016527:Drug Costs; D019458:Insurance Coverage
chemical_list: D000970:Antineoplastic Agents